AstraZeneca Settles Nexium Patent Dispute With Teva - WSJ.com

Links shared publicly online about this topic.

1,474
total visits

AstraZeneca Settles Nexium Patent Dispute With Teva - WSJ.com

The U.K.-based drug maker ended a long-running patent dispute with Teva, in a deal that will keep Teva's generic copies of blockbuster heartburn drug Nexium off the U.S. market until 2014.

View full resource at online.wsj.com

Tags: Heartburn Medication, H pylori Infection Medication, Erosive Esophagitis Medication, Stomach Ulcer Medication, Duodenal Ulcer Medication, Drug, Nexium, AstraZeneca

Most Recently Shared on January 7, 2010 at 10:12 am By:

WSJ Health

AstraZeneca Settles Teva Dispute http://bit.ly/7GKljp

2 years ago...

Retweet

Favorite

AstraZeneca Settles Nexium Patent Dispute With Teva

commerce.wsj.com — “AstraZeneca Settles Nexium Patent Dispute With Teva” View full resource at commerce.wsj.com

Most Recently Shared on January 7, 2010 at 12:53 pm By:

Michael Blaiss, MD Doctor, Allergist, and Physician

AstraZeneca Settles Nexium Patent Dispute With Teva http://is.gd/5QYST

2 years ago...

Retweet

Favorite

Astra sees off Nexium threat with Teva | Reuters

uk.reuters.com — “LONDON (Reuters) - AstraZeneca settled a U.S. patent row over Nexium with Israel's Teva Pharmaceuticals on Thursday, protecting the Anglo-Swedish drugmaker's top-selling heartburn” View full resource at uk.reuters.com